159 related articles for article (PubMed ID: 30819422)
1. Effect of two treatments on changes in serum acute phase protein concentrations in dogs with clinical leishmaniosis.
Daza González MA; Fragío Arnold C; Fermín Rodríguez M; Checa R; Montoya A; Portero Fuentes M; Rupérez Noguer C; Martínez Subiela S; Cerón JJ; Miró G
Vet J; 2019 Mar; 245():22-28. PubMed ID: 30819422
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment.
Martínez-Subiela S; Bernal LJ; Cerón JJ
Am J Vet Res; 2003 Aug; 64(8):1021-6. PubMed ID: 12926596
[TBL] [Abstract][Full Text] [Related]
3. Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial.
Medkour H; Bitam I; Laidoudi Y; Lafri I; Lounas A; Hamidat HK; Mekroud A; Varloud M; Davoust B; Mediannikov O
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008947. PubMed ID: 33338041
[TBL] [Abstract][Full Text] [Related]
4. Short term impacts of meglumine antimoniate treatment on kidney function in dogs with clinical leishmaniosis.
Daza González MA; Miró G; Fermín Rodríguez M; Rupérez Noguer C; Fragío Arnold C
Res Vet Sci; 2019 Oct; 126():131-138. PubMed ID: 31491669
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
[TBL] [Abstract][Full Text] [Related]
6. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
[TBL] [Abstract][Full Text] [Related]
7. Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol.
Gonçalves G; Campos MP; Gonçalves AS; Medeiros LCS; Figueiredo FB
Parasit Vectors; 2021 Dec; 14(1):599. PubMed ID: 34886876
[TBL] [Abstract][Full Text] [Related]
8. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
Amusategui I; Sainz A; Tesouro MA
Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510
[No Abstract] [Full Text] [Related]
9. Changes in the concentration of anti-Leishmania antibodies in saliva of dogs with clinical leishmaniosis after short-term treatment.
Cantos-Barreda A; Escribano D; Cerón JJ; Tecles F; Bernal LJ; Martínez-Subiela S
Vet Parasitol; 2018 Apr; 254():135-141. PubMed ID: 29656998
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum anti-Leishmania antibody levels and acute phase proteins in dogs with canine leishmaniosis.
Cantos-Barreda A; Escribano D; Cerón JJ; Bernal LJ; Furlanello T; Tecles F; Pardo-Marín L; Martínez-Subiela S
Vet Parasitol; 2018 Aug; 260():63-68. PubMed ID: 30197018
[TBL] [Abstract][Full Text] [Related]
11. Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate.
Saridomichelakis MN; Xenoulis PG; Chatzis MK; Kasabalis D; Steiner JM; Suchodolski JS; Petanides T
Vet Parasitol; 2013 Oct; 197(1-2):22-8. PubMed ID: 23685064
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study.
Kasabalis D; Chatzis MK; Apostolidis K; Xenoulis PG; Buono A; Petanides T; Leontides LS; Polizopoulou ZS; Steiner JM; Suchodolski JS; Saridomichelakis MN
Exp Parasitol; 2019 Nov; 206():107768. PubMed ID: 31539540
[TBL] [Abstract][Full Text] [Related]
13. Acute phase protein response in experimental canine leishmaniasis.
Martinez-Subiela S; Strauss-Ayali D; Cerón JJ; Baneth G
Vet Parasitol; 2011 Aug; 180(3-4):197-202. PubMed ID: 21511399
[TBL] [Abstract][Full Text] [Related]
14. A randomized, blinded, controlled clinical trial comparing the efficacy of aminosidine (paromomycin)-allopurinol combination with the efficacy of meglumine antimoniate-allopurinol combination for the treatment of canine leishmaniosis due to Leishmania infantum.
Kasabalis D; Chatzis MK; Apostolidis K; Petanides T; Athanasiou LV; Xenoulis PG; Mataragka A; Ikonomopoulos J; Leontides LS; Saridomichelakis MN
Exp Parasitol; 2020 Jul; 214():107903. PubMed ID: 32360142
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the use of miltefosine, miltefosine plus allopurinol, and allopurinol in dogs with visceral leishmaniasis.
Dias ÁFLR; Ayres EDCBS; de Oliveira Martins DT; Maruyama FH; de Oliveira RG; de Carvalho MR; Almeida ADBPF; Teixeira ALS; Mendonça AJ; Sousa VRF
Exp Parasitol; 2020 Oct; 217():107947. PubMed ID: 32628971
[TBL] [Abstract][Full Text] [Related]
16. Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy.
de Jong MK; Rappoldt A; Broere F; Piek CJ
Parasit Vectors; 2023 May; 16(1):163. PubMed ID: 37189181
[TBL] [Abstract][Full Text] [Related]
17. Serum ferritin and paraoxonase-1 in canine leishmaniosis.
Martinez-Subiela S; Cerón JJ; Strauss-Ayali D; Garcia-Martinez JD; Tecles F; Tvarijonaviciute A; Caldin M; Baneth G
Comp Immunol Microbiol Infect Dis; 2014 Jan; 37(1):23-9. PubMed ID: 24268430
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of serum pancreatic lipase immunoreactivity and troponin I concentrations in Leishmania infantum-infected dogs treated with meglumine antimonate.
Xenoulis PG; Saridomichelakis MN; Chatzis MK; Kasabalis D; Petanides T; Suchodolski JS; Steiner JM
Vet Parasitol; 2014 Jul; 203(3-4):326-30. PubMed ID: 24813787
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum.
Dos Santos CCP; Ramos GS; De Paula RC; Faria KF; Moreira POL; Pereira RA; Melo MN; Tafuri WL; Demicheli C; Ribeiro RR; Azevedo EG; Do Monte-Neto R; Da Silva SM; Frézard F
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32284386
[TBL] [Abstract][Full Text] [Related]
20. Randomized, allopurinol-controlled trial of the effects of dietary nucleotides and active hexose correlated compound in the treatment of canine leishmaniosis.
Segarra S; Miró G; Montoya A; Pardo-Marín L; Boqué N; Ferrer L; Cerón J
Vet Parasitol; 2017 May; 239():50-56. PubMed ID: 28495197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
